Clear Harbor Asset Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Clear Harbor Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$1.72 - $3.39 $8,600 - $16,950	5,000 Added 47.17%	15,600 $46,000
Q4 2021 Jan 21, 2022	SELL	$3.23 - $4.6 $4,845 - $6,899	-1,500 Reduced 12.4%	10,600 $36,000
Q2 2021 Aug 06, 2021	SELL	$3.94 - $4.92 $3,546 - $4,428	-900 Reduced 6.92%	12,100 $53,000
Q1 2021 Apr 14, 2021	BUY	$4.23 - $6.55 $54,990 - $85,150	13,000 New	13,000 $59,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.